In a meta-analysis of predominantly observational data, blood transfusion was independently associated with adverse outcomes in patients with myocardial infarction. These findings are consistent with previously published research, but clinical application of these data is hindered by the lack of prospective, randomized trials and the inherent bias in observational studies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Red blood cell transfusion in patients with ST-elevation myocardial infarction—a meta-analysis of more than 21,000 patients
Netherlands Heart Journal Open Access 23 July 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chatterjee, S., Wetterslev, J., Sharma, A., Lichstein, E. & Mukherjee, D. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. Arch. Intern. Med. http://dx.doi.org/10.1001/2013.jamainternmed.1001.
Lee, P. C., Kini, A. S., Ahsan, C., Fisher, E. & Sharma, S. K. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J. Am. Coll. Cardiol. 44, 541–546 (2004).
Yang, X. et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J. Am. Coll. Cardiol. 46, 1490–1495 (2005).
Rao, S. V. & Califf, R. M. Is old blood bad blood? Am. Heart J. 159, 710–712 (2010).
Cooper, H. A. et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot study). Am. J. Cardiol. 108, 1108–1111 (2011).
Carson, J. L. et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann. Intern. Med. 157, 49–58 (2012).
Subherwal, S. et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) bleeding score. Circulation 119, 1873–1882 (2009).
Alexander, K. P. et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294, 3108–3116 (2005).
Stone, G. W. Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 358, 2218–2230 (2008).
Romagnoli, E. et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial versus Femoral Randomized Investigation in ST-elevation Acute Coronary Syndrome) study. J. Am. Coll. Cardiol. 60, 2481–2489 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S. V. Rao declares that he is a consultant for The Medicines Company and Terumo Medical. M. W. Sherwood declares no competing interests.
Rights and permissions
About this article
Cite this article
Sherwood, M., Rao, S. Blood transfusion in patients with acute MI and anaemia. Nat Rev Cardiol 10, 186–187 (2013). https://doi.org/10.1038/nrcardio.2013.14
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2013.14
This article is cited by
-
Red blood cell transfusion in patients with ST-elevation myocardial infarction—a meta-analysis of more than 21,000 patients
Netherlands Heart Journal (2018)
-
S-nitrosylation boon to blood transfusions
Science-Business eXchange (2013)